Crossmark

Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer's Disease: A Double-Blind Masked Clinical Trial for Dose Finding

Crossref DOI link: https://doi.org/10.14283/jpad.2022.38

Published Print: 2022-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ruiz, Agustín

Sánchez, D.

Lafuente, A.

Ortega, G.

Buendía, M.

Papasey, J.

Jimeno, S.Y.

Badia, F.P.

Palacio, M.E.

Abdelnour, C.

Ramírez-Toraño, F.

Maestú, F.

Sáez, M.E.

Tárraga, L.

Dagnelie, P.C.

Boada, M.
License Information

Text and Data Mining valid from 2022-07-01

Text and Data Mining valid from 2022-07-01

Version of Record valid from 2024-09-25
More Information

This article is maintained by: Elsevier

Article Title: Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer's Disease: A Double-Blind Masked Clinical Trial for Dose Finding

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2022.38

Content Type: article

Copyright: Copyright © 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below